Credicorp Ltd Stock
Credicorp Ltd Stock
We can see a decrease in the price for Credicorp Ltd. Compared to yesterday it has lost -€4.000 (-1.710%).
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Credicorp Ltd.
With a target price of 252 € there is a slightly positive potential of 9.57% for Credicorp Ltd compared to the current price of 230.0 €.
So far the community has only identified positive things for Credicorp Ltd stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Credicorp Ltd in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Credicorp Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Credicorp Ltd | -1.710% | 5.505% | 4.545% | 27.072% | 34.503% | 69.118% | 71.642% |
| Comerica Inc. | 0.000% | 4.317% | 5.839% | 9.848% | 21.849% | 14.173% | 64.773% |
| Citigroup Inc. | -0.700% | 5.787% | 7.377% | 37.068% | 38.570% | 121.070% | 94.190% |
| Citizens Financial | 0.600% | 1.903% | 7.168% | 8.430% | 15.709% | 27.434% | 61.875% |
Comments
Credicorp (NYSE:BAP) had its price target raised by analysts at JPMorgan Chase & Co. from $242.00 to $310.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BAP provided by MarketBeat
Credicorp (NYSE:BAP) had its price target raised by analysts at UBS Group AG from $257.00 to $318.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BAP provided by MarketBeat
Credicorp (NYSE:BAP) had its price target raised by analysts at Citigroup Inc. from $255.00 to $275.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BAP provided by MarketBeat
News
Credicorp Ups ROE on Digital Gains
Credicorp(NYSE:BAP) reported Q2 2025 results on August 14, 2025, delivering a 20.7% return on equity (ROE) and raising full-year ROE guidance to approximately 19%. The quarter featured robust
